Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
Journal of Cutaneous Medicine and Surgery
|
April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT
Piergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.
Dermatology and Therapy
|
January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Diamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Dermatology and Therapy
|
February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Jonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.
Multiple Sclerosis and Related Disorders
|
December 9, 2022
Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis
Yuan-Ting Chang, Patrick K A Kearns, Alan Carson, et al.
Immunotherapy
|
September 1, 2025
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
The Journal of Allergy and Clinical Immunology
|
November 10, 2024
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
The Journal of Investigative Dermatology
|
April 19, 2026
The role of biosimilars in enhancing global access to psoriasis treatment
Yasmina Behlock, Sean P Gavan, Thomas Graier, et al.
Brain Communications
|
October 10, 2024
Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration
Rozanna Meijboom, Peter Foley, Niall J J MacDougall, et al.
BMJ Open
|
June 29, 2022
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis
Patrick K A Kearns, Sarah J Martin, Jessie Chang, et al.
Journal of the American Academy of Dermatology
|
October 28, 2022
Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting
Claire Felmingham, Yan Pan, Yonatan Kok, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
Journal of Cutaneous Medicine and Surgery
|
April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT
Piergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.
Dermatology and Therapy
|
January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Diamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Dermatology and Therapy
|
February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Jonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.
Multiple Sclerosis and Related Disorders
|
December 9, 2022
Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis
Yuan-Ting Chang, Patrick K A Kearns, Alan Carson, et al.
Immunotherapy
|
September 1, 2025
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
The Journal of Allergy and Clinical Immunology
|
November 10, 2024
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, et al.
The Journal of Investigative Dermatology
|
April 19, 2026
The role of biosimilars in enhancing global access to psoriasis treatment
Yasmina Behlock, Sean P Gavan, Thomas Graier, et al.
Brain Communications
|
October 10, 2024
Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration
Rozanna Meijboom, Peter Foley, Niall J J MacDougall, et al.
BMJ Open
|
June 29, 2022
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis
Patrick K A Kearns, Sarah J Martin, Jessie Chang, et al.
Journal of the American Academy of Dermatology
|
October 28, 2022
Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting
Claire Felmingham, Yan Pan, Yonatan Kok, et al.
Page
of 19